sakuranetin has been researched along with Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Câmara, NOS; de Arruda Martins, M; de Fátima Lopes Calvo Tibério, I; de Toledo, AC; Grecco, SDS; Hiyane, MI; Lago, JHG; Perini, A; Pinheiro, NM; Prado, CM; Righetti, RF; Sakoda, CPP | 1 |
| Bittencourt-Mernak, MI; Câmara, NO; Caperuto, LC; Felizardo, RJ; Grecco, SS; Guerreiro, MP; Lago, JH; Martins, MA; Pinheiro, NM; Prado, CM; Santana, FP; Saraiva-Romanholo, BM; Tibério, IF | 1 |
2 other study(ies) available for sakuranetin and Pneumonia
| Article | Year |
|---|---|
Sakuranetin reverses vascular peribronchial and lung parenchyma remodeling in a murine model of chronic allergic pulmonary inflammation.
Topics: Animals; Asthma; Chronic Disease; Collagen; Disease Models, Animal; Eosinophils; Flavonoids; Lung; Male; Mice, Inbred BALB C; Ovalbumin; Pneumonia | 2016 |
Prophylactic and therapeutic treatment with the flavonone sakuranetin ameliorates LPS-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Biomarkers; Cell Polarity; Collagen; Compliance; Cytokines; Flavonoids; Inflammation Mediators; Leukocytes; Lipopolysaccharides; Lung; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Models, Biological; Oxidative Stress; Phosphorylation; Pneumonia; Protein Subunits; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA | 2017 |